Clinical Trials Browser

INDUSTRY × Interventional × ABX464 × Clear all

NCT03760003 2025-11-28

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Phase 2 Completed

355 enrolled 39 charts

Colitis, Ulcerative